Renal survival. Kaplan-Meier curves of renal survival according to (A) hematological response (n = 169), (B) renal response (n = 166), (C) baseline eGFR (n = 169), (D) LCDD with or without associated CN (n = 138). Time to event was calculated from the day of the diagnosis of MIDD (D0). Renal survival proportions at 12, 36, and 60 months were 95%, 86%, 86% vs 70%, 62%, 51% in patients with and without VGPR/CR, respectively, and 97%, 91%, 91% vs 74%, 63%, 59% in renal responders vs nonresponders (P < .0001). NR, no response; PR, partial response.